• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Lyell Immunopharma released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 15K (forecast USD 0), actual EPS USD -2.1264 (forecast USD -2.6425)
04:00
Lyell Immunopharma released FY2025 9 Months Earnings on November 12 EST, with actual revenue of USD 30 K and EPS of USD -8.5528
04:00
Nov12
Lyell Initiates Phase III Clinical Trial for CAR T Cell Therapy in Aggressive B-Cell Lymphoma
21:05
Aug13
Lyell Immunopharma released FY2025 Semi-Annual Earnings on August 12 (EST), actual revenue USD 15K, actual EPS USD -6.422
03:00
Lyell Immunopharma released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 8 K (forecast USD 0), actual EPS USD -2.8854 (forecast USD -3.5833)
03:00
Jun26
Lyell Immunopharma Issues 625,000 Shares to ImmPACT Bio
20:07

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 15 K, Net Income -38.85 M, EPS -2.1264

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 8 K, Net Income -42.68 M, EPS -2.8854

Jun2
Reverse Stock Split(EST)

1-for-20 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More